| Literature DB >> 7717333 |
C L Mabee1, S W Mabee, P B Baker, R B Kirkpatrick, E J Levine.
Abstract
Etodolac is a new pyranocarboxylic acid nonsteroidal anti-inflammatory agent with a unique chemical structure indicated for use in patients with painful musculoskeletal disorders and rheumatoid disease. Hepatotoxicity, in the form of reversible elevations in transaminases or bilirubin, occurs rarely. We present the first reported case of fulminant hepatic failure related to etodolac.Entities:
Mesh：
Substances：
Year: 1995 PMID： 7717333
Source DB: PubMed Journal: Am J Gastroenterol ISSN： 0002-9270 Impact factor: 10.864